Russell Investments Group, Ltd. - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 62 filers reported holding CIDARA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,111
-16.6%
17,1000.0%0.00%
Q2 2023$19,323
-11.0%
17,1000.0%0.00%
Q1 2023$21,717
+67.9%
17,1000.0%0.00%
Q4 2022$12,932
+29.3%
17,1000.0%0.00%
Q3 2022$10,000
+25.0%
17,1000.0%0.00%
Q2 2022$8,000
-42.9%
17,1000.0%0.00%
Q1 2022$14,000
-33.3%
17,1000.0%0.00%
Q4 2021$21,000
-44.7%
17,1000.0%0.00%
Q3 2021$38,000
+11.8%
17,1000.0%0.00%
Q2 2021$34,000
-24.4%
17,1000.0%0.00%
Q1 2021$45,000
-70.2%
17,100
-72.3%
0.00%
Q1 2020$151,000
+344.1%
61,681
+561.3%
0.00%
Q4 2019$34,000
+3.0%
9,327
+22.7%
0.00%
Q3 2018$33,000
-19.5%
7,600
-3.8%
0.00%
Q2 2018$41,000
-54.9%
7,900
-65.2%
0.00%
Q1 2018$91,000
-42.0%
22,7000.0%0.00%
Q4 2017$157,000
+124.3%
22,700
+164.0%
0.00%
Q3 2017$70,000
+7.7%
8,6000.0%0.00%
Q2 2017$65,000
-62.4%
8,600
-46.6%
0.00%
Q4 2016$173,00016,1080.00%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 1,356,813$3,189,0004.48%
Omega Fund Management, LLC 1,508,794$3,546,0002.63%
ALETHEA CAPITAL MANAGEMENT, LLC 482,357$1,134,0001.65%
Opaleye Management Inc. 1,200,000$2,820,0001.05%
BVF INC/IL 2,904,684$6,826,0000.89%
FRAZIER MANAGEMENT LLC 1,312,258$3,084,0000.80%
Monashee Investment Management LLC 480,851$1,130,0000.76%
Aisling Capital LLC 1,021,148$2,400,0000.68%
Trellus Management Company, LLC 94,143$221,0000.50%
Prosight Management, LP 245,764$578,0000.30%
View complete list of CIDARA THERAPEUTICS INC shareholders